about
Large oncosomes mediate intercellular transfer of functional microRNA.Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells.miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells.miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activationApollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activationTowards the definition of prostate cancer-related microRNAs: where are we now?Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism.miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts.Emerging role of microRNAs in prostate cancer: implications for personalized medicine.MicroRNAs as new therapeutic targets and tools in cancer.RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapy.MicroRNA-dependent regulation of telomere maintenance mechanisms: a field as much unexplored as potentially promising.miRNAs in tumor radiation response: bystanders or participants?Targeting microRNAs to withstand cancer metastasis.Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells.MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs.Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types.miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis.Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches.Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin.Senescent stroma promotes prostate cancer progression: the role of miR-210.miR-205 impairs the autophagic flux and enhances cisplatin cytotoxicity in castration-resistant prostate cancer cells.microRNAs as players and signals in the metastatic cascade: Implications for the development of novel anti-metastatic therapies.Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.MicroRNAs in Cancer Management: Big Challenges for Small Molecules.miR-21: an oncomir on strike in prostate cancer.Clusterin: a potential target for improving response to antiestrogens.Photochemically enhanced delivery of a cell-penetrating peptide nucleic acid conjugate targeting human telomerase reverse transcriptase: effects on telomere status and proliferative potential of human prostate cancer cells.PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells.Predicting and Understanding Cancer Response to Treatment.Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairmentLEADeR role of miR-205 host gene as long noncoding RNA in prostate basal cell differentiationmiR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibitionGene expression dataset of prostate cells upon MIR205HG/LEADR modulationmiR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 SuppressionSplicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesotheliomaCoated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer modelsCore Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations
P50
Q30570006-6EBB2F05-D28E-4169-802C-8E8DE4329200Q33617345-4BF87F39-BBB1-4130-87AA-C9C649E2170AQ33909637-68C914A2-AA3A-4829-A0D0-08CAA307069BQ34952175-685E5E73-A511-40E4-9AD7-E521C74C6119Q36544603-1F8DD67F-3EF7-456C-AA88-78EAA7B0B958Q37123542-5F854516-99D3-4D80-BCDE-1929D0E5208DQ37589112-DDDA2BE4-5CDE-44B7-ABB6-A4CD184A0C2DQ37591581-2F7C8445-0DC8-44FB-A6D8-07BCC1525C39Q37593531-883EC402-2A15-41D0-986D-45B2F75B3257Q37720811-8E97E07F-8EB0-49EC-8FCC-7D5AFB295E93Q37826192-5AA9C82F-5265-44F5-9448-DC57535A7F13Q37971100-C94D989C-CA6A-49EE-9AA0-8BBE65BF7760Q38224270-23BB2CCD-B5CA-48D8-9924-F191132218AAQ38242941-A3CF82B2-DD12-4DDA-A83E-D6ABA2761734Q38260611-4CB6615A-CDB3-44D4-A3ED-0D91A72B6526Q38329911-CE88D55E-0E41-4468-AA81-CA22AB80CD7EQ38339177-A4D7F6C9-30C3-4F57-A137-FF6049F2CE59Q38380314-59A935DC-45DF-4120-B90A-171146B8FCFEQ38576565-D4880A52-D962-4D7B-9DCB-7C85F91DB473Q38713064-909C204A-F27F-4835-82D8-B07534BEFB62Q38771880-30449AAD-5AEE-4E9B-96FC-F8FFE864D295Q38878268-D109C68B-759C-4548-8ACF-85C501E78DFBQ38968807-ECAB96C9-8B9C-467C-B701-3561B58925D6Q39039757-2FDD407A-68E3-41BC-B2C8-2ACDB0BE9A26Q39201324-34114D59-899D-4F7F-9504-62C34AC14EDAQ39304697-33B1195B-9065-4413-9A27-A98D280939D7Q39327232-CBA70E4C-B043-4A18-8D5B-DAB229CD251CQ39749407-AD55BA48-F6D9-4B5E-8382-0B195572F771Q39936530-3BB56D0C-CC0D-4749-9A74-9A7DA8D5CC58Q40049879-B5619A48-CA1F-473E-9E7F-A31B76671B74Q51554544-7B3C0A1B-FD7F-416C-8CBD-1E5D8648DA57Q55554986-2689B928-8979-460B-8FC1-214293218F7DQ60589813-839AA7C6-2E7A-455B-85F3-8375DB46F325Q60907341-3744314A-4D44-486D-974D-07AEC9383175Q61800290-78BE9E4D-5F47-4EC9-AD43-62A370469172Q89521391-4F73B946-125A-46F5-85A6-A2C7249DA4DBQ89761629-6F56E063-FC0C-49D6-9215-BC683311EE12Q90727627-FD36EA97-FD80-4E82-85E8-BEAD6DF91EDDQ91830419-642D49FE-9A63-4A3E-85FB-D9709ACB980BQ92758054-996B8AB7-AB2D-4D22-8D1C-EF897373E5DC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paolo Gandellini
@ast
Paolo Gandellini
@en
Paolo Gandellini
@es
Paolo Gandellini
@nl
type
label
Paolo Gandellini
@ast
Paolo Gandellini
@en
Paolo Gandellini
@es
Paolo Gandellini
@nl
prefLabel
Paolo Gandellini
@ast
Paolo Gandellini
@en
Paolo Gandellini
@es
Paolo Gandellini
@nl
P106
P1153
16230044500
P31
P496
0000-0002-7811-3377